Sign up for a free trial now

Login
Subscribe
Take a FREE Trial

About Us
Contact us
RSS

22 May 2013

Search

The Pharma Letter

Home
7 Day Premium Trial
Pharmaceuticals
Biotechnology
Generics
Events
Companies
Drugs
Subscribe

Mesalamine Delayed-Release Tablets, Oral Articles

Procter & Gamble quits Rx Pharma, selling unit to Warner Chilcott for $3.1 billion

25 August 2009

Showing 1-1 of 1 articles

Go to beginning

Previous

1

Next

Go to end

Hot Topics
Most Read

Is failure to adopt business process management putting the pharma industry at risk?
AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
Boehringer Ingelheim gets FDA warning letter on cGMP failures

Is failure to adopt business process management putting the pharma industry at risk?
AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
Boehringer Ingelheim gets FDA warning letter on cGMP failures

© 2013 thepharmaletter.com

Home
RSS
About Us
Subscribe
Terms and Conditions
Article Archive

Site powered by WORKSsitebuilder CMS